GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...

Researchers evaluated whether corticosteroid treatment during acute SARS-CoV-2 infection decreases the risk for long COVID in pediatric patients.

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

Metformin does not significantly reduce the risk for long COVID at 6 months in low-risk adults with high baseline immunity to the virus.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Romain Sonneville, ...

The multisystem presentation of long-haul coronavirus disease 2019 (COVID-19) displays striking similarity with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Moreover, the particular ...

Several months after the COVID-19 pandemic started, I began seeing COVID-19 survivors who suffered from a variety of symptoms long after they were first infected. They mainly complained about ...

Researchers at the Harvard-affiliated Brigham and Women’s Hospital found that the Covid-19 antigen is twice as likely to be present in patients suffering from long Covid-19 compared to their ...

Authors of an editorial commentary in Clinical Infectious Diseases reviewed evidence from randomized trials and real-world analyses to evaluate why metformin should be offered to adults with COVID-19 ...

Adult cancer survivors in the United States were more likely to report severe COVID-19 symptoms compared to the general population, based on data from a new study of nearly 9000 individuals presented ...